npj Vaccines
A multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines.
Sustaining Immunity against Rabies: Insights from Cambodia's Post-Exposure Prophylaxis Protocol
Our study from the Institut Pasteur du Cambodge explores the long-term immunity of Cambodia’s rabies post-exposure prophylaxis protocol. It highlights antibody and T-cell responses, supporting efforts to control rabies with innovative, resource-efficient strategies in low-resource settings.
HPV vaccination and antibody-based surveillance: how much is enough for protection?
Behind the paper ‘Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study’
Clinical Testing of the cAd3-Ebola and MVA-EbolaZ vaccines
In two parallel phase I/Ib trials, both cAd3-vectored Ebola and MVA-EbolaZ vaccines were safe and well tolerated in healthy adults recruited from the United States and Uganda. The vaccines were immunogenic and elicited durable antibody responses.
